Brain metastases: Real-life treatment patterns, survival and patient-reported outcomes - Results from a populationbased, prospective study in 914 patients

Radiotherapy (RT) is frequently used in brain metastases (BM) treatment. RCTs show equal survival after stereotactic RT (SRT) and whole-brain RT (WBRT) in patients with favorable prognostic factors (i.e. ≤4 BM, good performance status [PS]), while WBRT may not improve survival in patients with more advanced cancer. We investigated what type of anticancer treatments pts were offered at the time of primary BM diagnosis. Patients were grouped according to anticancer treatments and known prognostic criteria.